Suppr超能文献

[神经皮肤综合征患者的临床特征]

[Clinical characterization in patients with neurocutaneous syndrome].

作者信息

Hernández-Castañeda Yazmin, Juárez-Melchor Daniela, Vera-Loaiza Aurea, Pérez-Arzola Alan Alberto, Crisanto-López Israel Enrique, Rodríguez-Hurtado Pablo Omar

机构信息

Instituto Mexicano del Seguro Social, Hospital General de Zona No. 20, Servicio de Genética Médica. Puebla, Puebla, México.

出版信息

Rev Med Inst Mex Seguro Soc. 2025 Mar 3;63(2):e6419. doi: 10.5281/zenodo.14616948.

Abstract

BACKGROUND

Neurocutaneous syndromes are a group of genetic diseases that affect the skin, eyes, central and peripheral nervous systems. They include Neurofibromatosis type 1 (NF1), Tuberous sclerosis (TS), Von-Hippel Lindau disease, Neurofibromatosis type 2 (NF2), Ataxia Telangiectasia (AT) and Hypomelanosis of Ito.

OBJECTIVE

To characterize the most frequent clinical manifestations in Neurocutaneous syndromes.

METHODS

A descriptive, observational, cross-sectional and ambivalent study was carried out in the Genetics service of the General Hospital of Zone No. 20. Patients diagnosed with any neurocutaneous syndrome of any age were included and agreed to participate in the study.

RESULTS

Thirty-nine patients were reviewed, 21 patients (53.8%) were women and 18 (46.2%) were men. The median age of the patients was 12 years, with an interquartile range (25th-75th percentiles) of 6 and 17 years, respectively. The most frequent neurocutaneous syndromes were NF1 (62%) and ET (18%). All patients presented cutaneous manifestations, and 16 patients (42.1%) presented at least one neurological manifestation.

CONCLUSIONS

The timely interpretation of skin changes as primary lesions becomes a valuable instrument for the early identification of any neurological alteration; likewise, the search for skin changes should be carried out in all patients undergoing initial study for neurological manifestations.

摘要

背景

神经皮肤综合征是一组影响皮肤、眼睛、中枢和周围神经系统的遗传性疾病。它们包括1型神经纤维瘤病(NF1)、结节性硬化症(TS)、冯·希佩尔·林道病、2型神经纤维瘤病(NF2)、共济失调毛细血管扩张症(AT)和伊藤色素减退症。

目的

描述神经皮肤综合征最常见的临床表现。

方法

在第20区综合医院的遗传学服务部门进行了一项描述性、观察性、横断面和双盲研究。纳入任何年龄被诊断患有任何神经皮肤综合征且同意参与研究的患者。

结果

共审查了39例患者,其中21例(53.8%)为女性,18例(46.2%)为男性。患者的中位年龄为12岁,四分位间距(第25-75百分位数)分别为6岁和17岁。最常见的神经皮肤综合征是NF1(62%)和ET(18%)。所有患者均有皮肤表现,16例(42.1%)患者至少有1种神经学表现。

结论

将皮肤变化及时解读为原发性病变成为早期识别任何神经学改变的重要手段;同样,对于所有因神经学表现接受初步检查的患者,都应进行皮肤变化的检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d5c/12040391/489035a1e2c5/04435117-63-2-e6419-c001.jpg

相似文献

1
[Clinical characterization in patients with neurocutaneous syndrome].
Rev Med Inst Mex Seguro Soc. 2025 Mar 3;63(2):e6419. doi: 10.5281/zenodo.14616948.
2
Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Postgrad Med. 2019 Sep;131(7):445-452. doi: 10.1080/00325481.2019.1659708. Epub 2019 Sep 12.
3
Intra-cranial manifestations of the neurocutaneous syndromes.
Clin Radiol. 2000 Feb;55(2):82-98. doi: 10.1053/crad.1999.0328.
6
Introduction to phacomatoses (neurocutaneous disorders) in childhood.
Childs Nerv Syst. 2020 Oct;36(10):2229-2268. doi: 10.1007/s00381-020-04758-5. Epub 2020 Sep 17.
7
Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden.
JAMA Netw Open. 2023 Jul 3;6(7):e2325482. doi: 10.1001/jamanetworkopen.2023.25482.
8
[Phacomatosis and genetically determined tumors: the transition from childhood to adulthood].
Neurochirurgie. 2008 Oct;54(5):642-53. doi: 10.1016/j.neuchi.2008.07.004. Epub 2008 Aug 26.
9
Multidisciplinary neurocutaneous syndrome clinics: a systematic review and institutional experience.
Neurosurg Focus. 2022 May;52(5):E2. doi: 10.3171/2022.2.FOCUS21776.
10
Neurofibromatosis type1, type 2, tuberous sclerosis and Von Hippel-Lindau disease.
Childs Nerv Syst. 2023 Oct;39(10):2791-2806. doi: 10.1007/s00381-023-06160-3. Epub 2023 Oct 11.

本文引用的文献

1
The management of neurofibromatosis type 1 (NF1) in children and adolescents.
Expert Rev Neurother. 2024 Apr;24(4):409-420. doi: 10.1080/14737175.2024.2324117. Epub 2024 Feb 27.
2
Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden.
JAMA Netw Open. 2023 Jul 3;6(7):e2325482. doi: 10.1001/jamanetworkopen.2023.25482.
4
Hypomelanosis of Ito.
Indian J Pediatr. 2022 Nov;89(11):1117-1119. doi: 10.1007/s12098-022-04208-x. Epub 2022 Jun 22.
5
Neurological manifestations of neurofibromatosis type 1: our experience.
Neurologia (Engl Ed). 2022 Jun;37(5):325-333. doi: 10.1016/j.nrleng.2019.05.008. Epub 2021 May 26.
6
The genetics and diagnosis of pediatric neurocutaneous disorders: Neurofibromatosis and tuberous sclerosis complex.
Clin Dermatol. 2022 Jul-Aug;40(4):374-382. doi: 10.1016/j.clindermatol.2022.02.010. Epub 2022 Mar 4.
7
Neurosurgical Considerations of Neurocutaneous Syndromes.
Neurosurg Clin N Am. 2022 Jan;33(1):81-89. doi: 10.1016/j.nec.2021.09.013. Epub 2021 Oct 28.
8
Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.
NPJ Genom Med. 2021 Nov 15;6(1):95. doi: 10.1038/s41525-021-00258-w.
9
Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1.
Front Neurol. 2021 Sep 8;12:704639. doi: 10.3389/fneur.2021.704639. eCollection 2021.
10
Histological Patterns of Skin Lesions in Tuberous Sclerosis Complex: A Panorama.
Dermatopathology (Basel). 2021 Jul 4;8(3):236-252. doi: 10.3390/dermatopathology8030029.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验